Cargando…

Prognostic factors of 10-year radiographic outcome in early rheumatoid arthritis: a prospective study

INTRODUCTION: The objectives of this study were to determine the predictive factors of long-term radiographic outcome of rheumatoid arthritis (RA) and to describe the relationship between joint damage and disability over the course of the disease. METHODS: A cohort of 191 patients with early RA refe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Courvoisier, Natacha, Dougados, Maxime, Cantagrel, Alain, Goupille, Philippe, Meyer, Olivier, Sibilia, Jean, Daures, Jean Pierre, Combe, Bernard
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2592783/ https://www.ncbi.nlm.nih.gov/pubmed/18771585 http://dx.doi.org/10.1186/ar2498

Ejemplares similares

Serial determination of cyclic citrullinated peptide autoantibodies predicted five-year radiological outcomes in a prospective cohort of patients with early rheumatoid arthritis
por: Meyer, Olivier, et al.
Publicado: (2006)

Cytomegalovirus infection: friend or foe in rheumatoid arthritis?
por: Davignon, Jean-Luc, et al.
Publicado: (2021)

Impact of gender on the response and tolerance to abatacept in patients with rheumatoid arthritis: results from the ‘ORA’ registry
por: Nourisson, Cynthia, et al.
Publicado: (2017)

Variants of genes implicated in type 1 interferon pathway and B-cell activation modulate the EULAR response to rituximab at 24 weeks in rheumatoid arthritis
por: Juge, Pierre-Antoine, et al.
Publicado: (2017)

Comparative effectiveness of rituximab, abatacept, and tocilizumab in adults with rheumatoid arthritis and inadequate response to TNF inhibitors: prospective cohort study
por: Gottenberg, Jacques-Eric, et al.
Publicado: (2019)

Positive impact on 10-year outcome of the window of opportunity for conventional synthetic DMARDs in rheumatoid arthritis: results from the ESPOIR cohort
por: Kedra, Joanna, et al.
Publicado: (2022)

Markers of B-lymphocyte activation are elevated in patients with early rheumatoid arthritis and correlated with disease activity in the ESPOIR cohort
por: Gottenberg, Jacques-Eric, et al.
Publicado: (2009)

Late-onset neutropenia after treatment with rituximab for rheumatoid arthritis and other autoimmune diseases: data from the AutoImmunity and Rituximab registry
por: Salmon, J H, et al.
Publicado: (2015)

Predictors of good response to conventional synthetic DMARDs in early seronegative rheumatoid arthritis: data from the ESPOIR cohort
por: Lukas, Cédric, et al.
Publicado: (2019)

Biomarkers in Rheumatoid Arthritis
por: Goëb, Vincent, et al.
Publicado: (2014)

Outcome of patients with early arthritis without rheumatoid factor and ACPA and predictors of rheumatoid arthritis in the ESPOIR cohort
por: Mouterde, Gaël, et al.
Publicado: (2019)

GUEPARD treat-to-target strategy is significantly more efficacious than ESPOIR routine care in early rheumatoid arthritis according to patient-reported outcomes and physician global estimate
por: Castrejón, Isabel, et al.
Publicado: (2013)

Matrix to predict rapid radiographic progression of early rheumatoid arthritis patients from the community treated with methotrexate or leflunomide: results from the ESPOIR cohort
por: Fautrel, Bruno, et al.
Publicado: (2012)

Infliximab concentration monitoring improves the control of disease activity in rheumatoid arthritis
por: Mulleman, Denis, et al.
Publicado: (2009)

Prognostic Factors for Radiographic Progression in Patients with Seronegative Rheumatoid Arthritis
por: Park, Eun-Jung, et al.
Publicado: (2021)

Diagnostic impact of routine Lyme serology in recent-onset arthritis: results from the ESPOIR cohort
por: Guellec, Dewi, et al.
Publicado: (2016)

Patient-reported outcomes as end points in clinical trials in rheumatoid arthritis
por: Gossec, Laure, et al.
Publicado: (2015)

Modulation of T-cell responses by anti-tumor necrosis factor treatments in rheumatoid arthritis: a review
por: Davignon, Jean-Luc, et al.
Publicado: (2018)

Performance of matrices developed to identify patients with early rheumatoid arthritis with rapid radiographic progression despite methotrexate therapy: an external validation study based on the ESPOIR cohort data
por: Granger, Benjamin, et al.
Publicado: (2016)

A new classification of HLA-DRB1 alleles differentiates predisposing and protective alleles for autoantibody production in rheumatoid arthritis
por: Gourraud, Pierre-Antoine, et al.
Publicado: (2007)

Lymphoma complicating rheumatoid arthritis: results from a French case–control study
por: Kedra, Joanna, et al.
Publicado: (2021)

Pathogenic role of platelets in rheumatoid arthritis and systemic autoimmune diseases: Perspectives and therapeutic aspects
por: Harifi, Ghita, et al.
Publicado: (2016)

Serum level of adiponectin is a surrogate independent biomarker of radiographic disease progression in early rheumatoid arthritis: results from the ESPOIR cohort
por: Meyer, Magali, et al.
Publicado: (2013)

Maintenance of cytomegalovirus-specific CD4(pos )T-cell response in rheumatoid arthritis patients receiving anti-tumor necrosis factor treatments
por: Davignon, Jean-Luc, et al.
Publicado: (2010)

Understanding emerging treatment paradigms in rheumatoid arthritis
por: Breedveld, Ferdinand C, et al.
Publicado: (2011)

In Antisynthetase Syndrome, ACPA Are Associated With Severe and Erosive Arthritis: An Overlapping Rheumatoid Arthritis and Antisynthetase Syndrome
por: Meyer, Alain, et al.
Publicado: (2015)

Efficacy and safety data based on historical or pre-existing conditions at baseline for patients with active rheumatoid arthritis who were treated with baricitinib
por: Combe, Bernard, et al.
Publicado: (2019)

A Risk Score to Detect Subclinical Rheumatoid Arthritis–Associated Interstitial Lung Disease
por: Juge, Pierre‐Antoine, et al.
Publicado: (2022)

Clinical, radiographic and immunogenic effects after 1 year of tocilizumab-based treatment strategies in rheumatoid arthritis: the ACT-RAY study
por: Dougados, Maxime, et al.
Publicado: (2014)

Determining a low disease activity threshold for decision to maintain disease-modifying antirheumatic drug treatment unchanged in rheumatoid arthritis patients
por: de Bandt, Michel, et al.
Publicado: (2009)

The effect of tofacitinib on residual pain in patients with rheumatoid arthritis and psoriatic arthritis
por: Dougados, Maxime, et al.
Publicado: (2022)

Predictive value of tender joints compared to synovitis for structural damage in rheumatoid arthritis
por: Cheung, Peter P, et al.
Publicado: (2016)

Reduced progression of bone erosion in cytomegalovirus seropositive rheumatoid arthritis patients
por: Rauwel, B., et al.
Publicado: (2020)

Glucocorticoids in rheumatoid arthritis: current status and future studies
por: Hua, Charlotte, et al.
Publicado: (2020)

IL-10 Producing B Cells Ability to Induce Regulatory T Cells Is Maintained in Rheumatoid Arthritis
por: Mielle, Julie, et al.
Publicado: (2018)

Prevention of Radiographic Progression in Higher-Risk Patients with Rheumatoid Arthritis Using Filgotinib in Phase III Studies: Narrative Review of Post Hoc Analyses
por: Tanaka, Yoshiya, et al.
Publicado: (2023)

Osteoprotegerin and tumor necrosis factor-related apoptosis-inducing ligand as prognostic factors in rheumatoid arthritis: results from the ESPOIR cohort
por: Audo, Rachel, et al.
Publicado: (2015)

Tofacitinib Prevents Radiographic Progression in Rheumatoid Arthritis
por: Kim, Joon Wan, et al.
Publicado: (2013)

Robust analyses for radiographic progression in rheumatoid arthritis
por: Landewé, Robert, et al.
Publicado: (2023)

DICER1: A Key Player in Rheumatoid Arthritis, at the Crossroads of Cellular Stress, Innate Immunity, and Chronic Inflammation in Aging
por: De Cauwer, Aurore, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_4jvemo3kd0unle2f2ekuus60di